AccuStem Sciences, Inc.
ACUT
$0.388
$0.11240.58%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.91M | 2.60M | 2.86M | 3.53M | 3.48M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.05M | 2.78M | 3.08M | 3.79M | 3.75M |
| Operating Income | -2.05M | -2.78M | -3.08M | -3.79M | -3.75M |
| Income Before Tax | -2.05M | -2.78M | -3.08M | -3.79M | -3.75M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.05 | -2.78 | -3.08 | -3.79 | -3.75 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.05M | -2.78M | -3.08M | -3.79M | -3.75M |
| EBIT | -2.05M | -2.78M | -3.08M | -3.79M | -3.75M |
| EBITDA | -2.05M | -2.78M | -3.08M | -3.79M | -3.74M |
| EPS Basic | -0.18 | -0.25 | -0.27 | -0.33 | -0.34 |
| Normalized Basic EPS | -0.11 | -0.15 | -0.17 | -0.21 | -0.21 |
| EPS Diluted | -0.18 | -0.25 | -0.27 | -0.33 | -0.34 |
| Normalized Diluted EPS | -0.11 | -0.15 | -0.17 | -0.21 | -0.21 |
| Average Basic Shares Outstanding | 45.39M | 45.39M | 45.38M | 45.37M | 44.06M |
| Average Diluted Shares Outstanding | 45.39M | 45.39M | 45.38M | 45.37M | 44.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
